Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
J Ethnopharmacol ; 290: 115077, 2022 May 23.
Artículo en Inglés | MEDLINE | ID: mdl-35131339

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: As a common medicinal and edible plant, Zingiber officinale Roscoe (ginger) is often used for the prevention of motion sickness. However, the mechanism of its anti-motion sickness remains to be elucidated. AIM OF THE STUDY: To explore novel treatment for motion sickness with less side effects, anti-motion sickness effect of ginger (Zingiber officinale) extract (GE) and the possible molecular mechanisms were investigated. MATERIALS AND METHODS: The anti-motion sickness effect of ginger was evaluated through mice animal experimental models. Components of ginger that might contribute to the anti-motion sickness effect were analyzed by LC-MS/MS. Subsequently, biochemical analysis integrated with serum metabolomic profiling were performed to reveal the systematic response of motion sickness mice to ginger extract's amelioration effect. RESULTS: Exhaustive swimming time of mice in the GE group reached 8.9 min, which was 52.2% longer than that in the model group. Motion sickness index scores and time taken traversing balance beam of mice in the GE group were decreased by 53.2% and 38.5%, respectively. LC-MS/MS analysis suggested that various active ingredients in GE, such as gingerol, ginger oil and terpenoids, might contribute to its appealing anti-motion sickness activity. Biochemical analysis revealed that GE can relieve motion sickness through reducing histamine and acetylcholine release in vestibular system, regulating fatty acid oxidation, sugar metabolism and bile acid metabolism in mice. CONCLUSION: Gavage of mice with GE can effectively relieve the symptoms of autonomic nervous system dysfunction, improve the balance and coordination ability and ameliorate the ability to complete complex work after rotation stimulation. GE has attractive potential for development and utilization as novel anti-motion sickness food or drugs.


Asunto(s)
Mareo por Movimiento/patología , Extractos Vegetales/farmacología , Zingiber officinale/química , Acetilcolina/metabolismo , Animales , Animales no Consanguíneos , Conducta Animal/efectos de los fármacos , Ácidos y Sales Biliares/metabolismo , Catecoles/farmacología , Cromatografía Liquida , Relación Dosis-Respuesta a Droga , Ácidos Grasos/metabolismo , Alcoholes Grasos/farmacología , Histamina/metabolismo , Masculino , Ratones , Aceites de Plantas/farmacología , Azúcares/metabolismo , Espectrometría de Masas en Tándem , Terpenos/farmacología
2.
Sci Rep ; 8(1): 10365, 2018 07 09.
Artículo en Inglés | MEDLINE | ID: mdl-29985388

RESUMEN

Motion sickness (MS) is an acute disorder that occurs in healthy individuals worldwide regardless of gender, age, or ethnicity. Our study used a mouse model to rule out the effects of any psychological factors related to MS and EA. Subjects were randomly separated into four groups, namely the control group (Con), motion sickness inducing group (MS), mentioning sickness inducing with electroacupuncture treatment group (EA) and motion sickness inducing only in TRPV1 knockout mice group (TRPV1-/-). The consumption of kaolin, a non-nutrient substance, was measured as a behavior observed response of an emetic reflex in a murine model. This behavior is referred to as pica behavior. Our results showed that pica behavior was observed in the MS group. Moreover, kaolin consumption in the EA group decreased to the average baseline of the control group. A similar result was observed in TRPV1 null mice. We also observed an increase of TRPV1 and related molecules in the thalamus, hypothalamic and brain stem after MS stimulation and a significant decrease in the EA and TRPV1 null groups. This is the first study to demonstrate that TRPV1 pathways are possibly associated with mechanisms of MS, and can be attended through EA or TRPV1 genetic manipulation.


Asunto(s)
Electroacupuntura , Mareo por Movimiento/patología , Canales Catiónicos TRPV/genética , Animales , Tronco Encefálico/metabolismo , Modelos Animales de Enfermedad , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Eliminación de Gen , Hipotálamo/metabolismo , Caolín/administración & dosificación , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Mareo por Movimiento/genética , Mareo por Movimiento/terapia , FN-kappa B/metabolismo , Transducción de Señal/genética , Canales Catiónicos TRPV/deficiencia , Canales Catiónicos TRPV/metabolismo , Tálamo/metabolismo
3.
Prog Neurobiol ; 91(4): 300-12, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20416353

RESUMEN

The brainstem is a structurally complex region, containing numerous ascending and descending fibres that converge on centres that regulate bodily functions essential to life. Afferent input from the cranial tissues and the special senses is processed, in part, in brainstem nuclei. In addition, brainstem centres modulate the flow of pain messages and other forms of sensory information to higher regions of the brain, and influence the general excitability of these cortical regions. Thus, disruptions in brainstem processing might evoke a complex range of unpleasant symptoms, vegetative changes and neurovascular disturbances and that, together, form attacks of migraine. Migraine is linked with various co-morbid conditions, the most prominent being motion sickness. Symptoms such as nausea, dizziness and headache are common to motion sickness and migraine; moreover, migraine sufferers have a heightened vulnerability to motion sickness. As both maladies involve reflexes that relay in the brainstem, symptoms may share the same neural circuitry. In consequence, subclinical interictal persistence of disturbances in these brainstem pathways could not only increase vulnerability to recurrent attacks of migraine but also increase susceptibility to motion sickness. Mechanisms that mediate symptoms of motion sickness and migraine are explored in this paper. The physiology of motion sickness and migraine is discussed, and neurotransmitters that may be involved in the manifestation of symptoms are reviewed. Recent findings have shed light on the relationship between migraine and motion sickness, and provide insights into the generation of migraine attacks.


Asunto(s)
Trastornos Migrañosos/complicaciones , Mareo por Movimiento/complicaciones , Animales , Tronco Encefálico/fisiopatología , Enfermedades Gastrointestinales/complicaciones , Humanos , Hipotálamo/fisiopatología , Trastornos Migrañosos/patología , Mareo por Movimiento/patología , Serotonina/metabolismo , Enfermedades Vasculares/complicaciones , Enfermedades Vestibulares/complicaciones
4.
Acta Otolaryngol ; 129(1): 45-51, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18607976

RESUMEN

CONCLUSION: The study findings suggest that histamine was released from the axon terminals in the hypothalamus and brainstem and the released histamine activated post-synaptic H1 receptors there, resulting in the development of motion sickness. OBJECTIVES: We first examined which subtype of post-synaptic histaminergic receptor was responsible for the development of motion sickness. We then examined whether H1 receptors were up-regulated in various areas of the rat brain after 2 G hypergravity load, because the stimulation of H1 receptor was reported to up-regulate the level of H1 receptor protein expression through augmentation of H1 receptor mRNA expression. MATERIALS AND METHODS: For this purpose, we used an animal model of motion sickness, using pica (eating non-nutritive substances such as kaolin), as a behavioral index in rats. RESULTS: After 2 G hypergravity load, rats ate a significant amount of kaolin, indicating that they suffered from motion sickness. The hypergravity-induced kaolin intake was suppressed by mepyramine, but not by terfinadine or zolantizine. This finding indicates that cerebral post-synaptic H1 but not H2 or peripheral H1 receptors play an important role in the development of motion sickness. The expression of H1 receptor mRNA was up-regulated in the hypothalamus and brainstem, but not in the cerebral cortex after 2 G hypergravity load in rats.


Asunto(s)
Tronco Encefálico/fisiopatología , Hipergravedad/efectos adversos , Hipotálamo/fisiopatología , Mareo por Movimiento/genética , ARN Mensajero/genética , Receptores Histamínicos H1/genética , Animales , Tronco Encefálico/patología , Corteza Cerebral/patología , Corteza Cerebral/fisiopatología , Modelos Animales de Enfermedad , Expresión Génica/fisiología , Hipotálamo/patología , Masculino , Mareo por Movimiento/patología , Mareo por Movimiento/fisiopatología , Ratas , Ratas Wistar , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Regulación hacia Arriba/genética , Regulación hacia Arriba/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA